Type II nitric oxide synthase (NOS2) expression correlates with lymph node status in oral squamous cell carcinoma

Area of Science:

• Tumour biology
• Oncology
• Molecular pathology

Background:

• Nitric oxide (NO) has complex, concentration-dependent roles in tumour biology.
• Elevated NO levels in cancers are linked to increased angiogenesis and tumour spread.

Purpose of the Study:

• To investigate the expression of nitric oxide synthase type II (NOS2) in oral squamous cell carcinoma (OSCC).
• To correlate NOS2 expression with lymph node metastasis and clinicopathological features of OSCC.

Main Methods:

• Immunohistochemical analysis of NOS2 expression in 41 OSCC cases.
• Correlation of NOS2 staining with lymph node status, tumour size, differentiation, and smoking history.
• Western blotting to confirm NOS2 protein expression.

Main Results:

• Significant association found between NOS2 expression and lymph node metastasis (P<0.0002).
• Lymph node metastasis correlated with the degree and intensity of NOS2 staining (P<0.001).
• No correlation observed between NOS2 staining and primary tumour size, differentiation, or smoking status.

Conclusions:

• NOS2 expression is not universal in oral cancer but is significantly linked to lymph node metastasis.
• NOS2 may serve as a valuable biomarker for assessing lymph node status in OSCC patients.
• NOS2 represents a potential therapeutic target for oral cancer treatment.